SIRT1 and leukemia: Although the signaling pathways that lead to chemoresistance are still being explored, there is evidence that supports the participation of SIRT1; therefore, knowing the role of SIRT1 in the induction of drug resistance in leukemia would allow us to propose treatment strategies that prevent and reverse the chemoresistant phenotype, thus contributing to improving the survival rate.